Bioglan licenses Solarase

Bioglan (LSE:BGP) received an exclusive EU license from SkyePharma (LSE:SKP; SKYE) to manufacture and sell Solarase to treat actinic keratoses. BGP will pay a license fee and royalties. Solarase is ap...